1910 Genetics
Multimodal AI Platform for Modality Agnostic Drug Discovery
About 1910 Genetics
1910 Genetics is an AI-native biotech integrating massive multimodal data, frontier AI models, and high-throughput lab automation to discover small and large molecule therapeutics.
1910 Genetics is an AI-native biotech company that integrates massive multimodal data, frontier AI models, and high-throughput lab automation into an infrastructure for AI-enabled drug discovery. The company focuses on both small and large molecule therapeutics and has developed platforms such as ITO, PEGASUS, and CANDID-CNS for drug design and discovery.
The company serves biotech and pharmaceutical organizations through partnerships and co-engineering collaborations. These allow partners to use 1910's data, AI models, optimized compute, and interactive tools to build bespoke discovery modules for their own use. 1910 also maintains its own pipeline of drug modalities across major disease areas.
Revenue is generated through strategic partnerships and platform access, while the company continues to publish research and develop advanced AI models for drug discovery.
Open roles at 1910 Genetics
Work at 1910 Genetics? Claim this page to keep it up to date.